Avai Bio (AVAI) EV to EBITDA (2020 - 2026)

Avai Bio has disclosed EV to EBITDA across 7 years of filings, most recently posting 36.09 for Q2 2026.

• In Q2 2026, EV to EBITDA fell 121.69% year-over-year to 36.09; the TTM figure through Jun 2026 stood at 10.98 (up 83.95% YoY), while the FY2026 annual figure was 28.03, up 51.38% from the prior year.
• EV to EBITDA came in at 36.09 for Q2 2026 at Avai Bio, up from 192.04 in the prior quarter.
• In the past five years, EV to EBITDA ranged from a high of 4308.89 in Q1 2022 to a low of 192.04 in Q1 2026.
• Average EV to EBITDA over 5 years is 350.76, with a median of 76.7 recorded in 2023.
• Year-over-year, EV to EBITDA soared 625.72% in 2022 and slumped 701.46% in 2026.
• Over 5 years, EV to EBITDA stood at 369.07 in 2022, then plunged by 84.82% to 56.03 in 2023, then surged by 181.36% to 157.65 in 2024, then sank by 160.03% to 94.63 in 2025, then jumped by 61.86% to 36.09 in 2026.
• Per Business Quant data, the three most recent EV to EBITDA figures were 36.09 in Q2 2026, 192.04 in Q1 2026, and 94.63 in Q4 2025.